...
首页> 外文期刊>BMC Infectious Diseases >Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia
【24h】

Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia

机译:多重耐药性结核病:埃塞俄比亚西北部水肿和西阿马奇霍地区的患病率和危险因素

获取原文
           

摘要

Multi drug resistant tuberculosis (MDR-TB) is an emerging challenge for TB control programs globally. According to World health organization, 2012 report Ethiopia stands 15th out of the 27 high priority countries in the world and 3rd in Africa. Updated knowledge of the magnitude of MDR-TB is so substantial to allocate resources, and to address prevention and control measures. Therefore, the aim of this study was to assess the prevalence of MDR-TB and associated risk factors in West Armachiho and Metema districts of North Gondar. A cross-sectional study was conducted in West Armachiho and Metema districts between February 01 and June 25, 2014. A total of 124 consecutive smear positive pulmonary tuberculosis patients were included in the study. Socio-demographic and possible risk factor data were collected using a semi-structured questionnaire. Drug susceptibility testing was first performed for rifampicin using GeneXpert MTB/RIF. For those rifampicin resistant strains, drug susceptibility testing was performed for both isoniazid and rifampicin to identify MDR-TB using the proportional method on LJ media. Data were analyzed using statistical Package SPSS version 20; binary logistic regression was used to assess the association. P-values?
机译:耐多药结核病(MDR-TB)是全球结核病控制计划面临的新挑战。根据世界卫生组织的报告,2012年报告埃塞俄比亚在世界27个高度优先国家中排名第15位,在非洲排名第3位。对耐多药结核病规模的最新了解对于分配资源以及解决预防和控制措施是如此重要。因此,本研究的目的是评估北贡德尔西Armachiho和Metema地区的MDR-TB患病率及相关危险因素。 2014年2月1日至6月25日在西Armachiho和Metema地区进行了一项横断面研究。该研究共纳入了124名连续涂片阳性的肺结核患者。使用半结构问卷收集了社会人口统计数据和可能的危险因素数据。首先使用GeneXpert MTB / RIF对利福平进行药敏试验。对于那些对利福平耐药的菌株,在LJ培养基上使用比例法对异烟肼和利福平进行了药敏试验,以鉴定MDR-TB。使用统计软件包SPSS 20版分析数据。二元逻辑回归用于评估关联。 P值≤0.05被认为具有统计学意义。在124例涂片阳性的肺结核患者中,有117名(94.4%)对利福平敏感,而7名(5.7 %%)被证实对利福平和异烟肼有抗药性。耐多药结核病的总体患病率为5.7%(新病例为2.3%,先前治疗的病例为13.9%)。既往治疗史(OR?=?7,P?=?0.025)与MDR-TB的危险因素显着相关。在五个卫生中心的病例中,耐多药结核病的总体患病率为5.7%,以前的治疗史被认为是被耐多药结核病菌株感染的危险因素。因此,建议最大程度地尽早发现和治疗病例,加强结核病感染控制活动并适当实施DOTS以减轻耐多药结核病的负担。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号